Lexaria Bioscience Corp, a proprietary drug delivery technology, declares that a sanction has been received from an independent third-party ethics review board for human pilot study #2 (the "Study"), which examined GLP-1 medications and...
Compass Therapeutics, a biopharmaceutical firm, reported that the intial patient has been dosed in its stage 1 dose-escalation clinical preliminary of CTX-8371, a PD-1 x PD-L1 bispecific neutralizer, in patients with solid tumours. “Dosing the...
Cipla, a leading pharmaceutical firm will acquire the beauty care products and individual consideration circulation and marketing business of Ivia Beaute Pvt Ltd, including the brands Astaberry, Ikin and Bhimsaini, on an overall reason for...
In a significant leap forward for private healthcare practitioners, a revolutionary clinic management solution - Doc-Aid was launched in the city today.
New Delhi-based Varco Leg Care, the world’s first dedicated leg care brand, has raised a cumulative of US$ 0.5 Million (over INR 4.5 Cr) in seed funding, while doubling its valuation within a span of only 10 months
Glenmark Pharmaceuticals is in the process of pulling back 6,528 bottles of medication used for high blood pressure treatment from the American market due to issues with dissolution specifications, PTI reported citing the US Food and Drug Administrat
.jpg)
